These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2870677)

  • 21. Pili of Neisseria meningitidis. Analysis of structure and investigation of structural and antigenic relationships to gonococcal pili.
    Stephens DS; Whitney AM; Rothbard J; Schoolnik GK
    J Exp Med; 1985 Jun; 161(6):1539-53. PubMed ID: 2409203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a second generation group B meningococcal vaccine.
    Frasch CE; Sacchi CT; Brandiolone MC; Vieiera VS; Leite LC
    NIPH Ann; 1991 Dec; 14(2):225-30; discussion 230-1. PubMed ID: 1812436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospects for the prevention of meningococcal disease: special reference to group B.
    Frasch CE
    Vaccine; 1987 Mar; 5(1):3-4. PubMed ID: 3107234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis belt.
    Norheim G; Tunheim G; Næss LM; Kristiansen PA; Caugant DA; Rosenqvist E
    Scand J Immunol; 2012 Aug; 76(2):99-107. PubMed ID: 22537024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine against meningococcal group B disease.
    Lifely MR; Moreno C
    Lancet; 1986 Jan; 1(8474):214-5. PubMed ID: 2868239
    [No Abstract]   [Full Text] [Related]  

  • 26. [Gonococcal surface antigens and their significance for serotyping and vaccines].
    Kohl PK; Meyer TF; Petzoldt D
    Hautarzt; 1985 Jun; 36(6):320-5. PubMed ID: 2862130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Meningococcal meningitis: preliminary epidemiological results on the introduction of a prophylactic vaccine].
    Galli MG
    G Batteriol Virol Immunol; 1982; 75(7-12):251-4. PubMed ID: 7188258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The meningococcus tamed?
    Pollard AJ; Moxon ER
    Arch Dis Child; 2002 Jul; 87(1):13-7. PubMed ID: 12089113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development.
    Saukkonen K; Abdillahi H; Poolman JT; Leinonen M
    Microb Pathog; 1987 Oct; 3(4):261-7. PubMed ID: 3143885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children.
    Lepow ML; Beeler J; Randolph M; Samuelson JS; Hankins WA
    J Infect Dis; 1986 Dec; 154(6):1033-6. PubMed ID: 3097160
    [No Abstract]   [Full Text] [Related]  

  • 31. Polysaccharide meningococcal vaccines--current status.
    Gold R
    Hosp Pract; 1979 Dec; 14(12):41-8. PubMed ID: 116953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biology of the Gonococcus: Disease and Pathogenesis.
    Shaughnessy J; Ram S; Rice PA
    Methods Mol Biol; 2019; 1997():1-27. PubMed ID: 31119614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial outer membrane protein vaccines. The meningococcal example.
    Poolman JT
    Adv Exp Med Biol; 1996; 397():73-7. PubMed ID: 8718585
    [No Abstract]   [Full Text] [Related]  

  • 34. Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease.
    Fischer M; Carlone GM; Holst J; Williams D; Stephens DS; Perkins BA
    Vaccine; 1999 May; 17(19):2377-83. PubMed ID: 10392619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic].
    Wu C
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683
    [No Abstract]   [Full Text] [Related]  

  • 36. Meningococcal vaccines--present and future.
    Zollinger WD; Moran E
    Trans R Soc Trop Med Hyg; 1991; 85 Suppl 1():37-43. PubMed ID: 1803695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The primary sequence and antigenic structure of gonococcal pilin: approaches towards a gonococcal vaccine.
    Rothbard JB; Schoolnik GK
    Adv Exp Med Biol; 1985; 185():247-73. PubMed ID: 2416202
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of Neisseria meningitidis group A polysaccharide vaccine on nasopharyngeal carrier rates.
    Sivonen A
    J Infect; 1981 Sep; 3(3):266-72. PubMed ID: 6821094
    [No Abstract]   [Full Text] [Related]  

  • 39. Advancing vaccine development for gonorrhoea and the Global STI Vaccine Roadmap.
    Gottlieb SL; Jerse AE; Delany-Moretlwe S; Deal C; Giersing BK
    Sex Health; 2019 Sep; 16(5):426-432. PubMed ID: 31476278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immune bacteriolysis reaction in the assessment of immunological effectiveness of serogroup B meningococcal vaccine].
    Golovina LI; Kuvakina VI; Alliluev AP; Basnak'ian IA; Sivko RI
    Klin Lab Diagn; 1995; (1):26-9. PubMed ID: 7757362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.